Mezigdomide
Mezigdomide is the most potent oral cereblon modulator, producing responses in about 40% of triple-class-refractory myeloma with dexamethasone alone.
CC-92480-MM-001: ORR 41% (MeziDex) in heavily pretreated disease including 30% with extramedullary disease. SUCCESSOR-1 (Mezi-Vd vs Pom-Vd) and SUCCESSOR-2 (Mezi-Kd vs Kd) phase 3 trials ongoing.
Compare all products across the US, EU, UK, Japan, China and Australia →
Trials
topRecruiting now (live from ClinicalTrials.gov)
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Latest papers
topQuery for this drug: (TITLE:"Mezigdomide" OR ABSTRACT:"Mezigdomide" OR TITLE:"CC-92480" OR ABSTRACT:"CC-92480") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Mezigdomide, not a curated reading list.
Pages like this
not linked directly; found by shared links- ProductIberdomide
Shares Ubiquitin–proteasome system & protein homeostasis, PROTACs & molecular glues (targeted protein degradation), Bristol Myers Squibb, Multiple myeloma.
- ProductPomalidomide
Shares Ubiquitin–proteasome system & protein homeostasis, PROTACs & molecular glues (targeted protein degradation), Bristol Myers Squibb, Multiple myeloma.
- ProductGolcadomide
Shares Ubiquitin–proteasome system & protein homeostasis, PROTACs & molecular glues (targeted protein degradation), Bristol Myers Squibb.
- ProductThalidomide
Shares PROTACs & molecular glues (targeted protein degradation), Bristol Myers Squibb, Multiple myeloma.
- TermHigh-risk cytogenetics (myeloma)
Shares Ubiquitin–proteasome system & protein homeostasis, Multiple myeloma.
- ProductElotuzumab
Shares Bristol Myers Squibb, Multiple myeloma.
- TermR-ISS / R2-ISS staging
Shares Ubiquitin–proteasome system & protein homeostasis, Multiple myeloma.
- ProductIxazomib
Shares Ubiquitin–proteasome system & protein homeostasis, Multiple myeloma.